MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email: mrcctu.stampede2@ucl.ac.uk
STAMPEDE2 Welcomes First Patient to Comparison S
We are thrilled to share that the STAMPEDE2 trial has randomised its first patient into Comparison S at the Royal Marsden Hospital Chelsea, on Tuesday 9th July.
Comparison S aims to explore the potential benefits of adding Stereotactic Ablative Body Radiotherapy (SABR) to standard of care for men whose prostate cancer has spread to a limited number of body areas.
A big thank you to everyone contributing towards this important work.
STAMPEDE2